To include your compound in the COVID-19 Resource Center, submit it here.

GVAX: Updated Phase I/II data

Updated results from a U.S. Phase I/II trial in 22

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE